Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Great. Thanks, everyone, for joining. My name is Scott Schoenhaus. I am the health care tech equity analyst here at KeyBanc. We're a pleasure to have Ben Taylor, CFO of Recursion for a fireside chat.

Forbes contributors publish independent expert analyses and insights. John Sviokla covers GenAI/AI's impact on commerce and society. This voice experience is generated by AI. Learn more. This voice ...

Got a confidential news tip? We want to hear from you. Sign up for free newsletters and get more CNBC delivered to your inbox Get this delivered to your inbox, and ...

TL;DR: Turn messy ideas into polished diagrams with Microsoft Visio 2021 Professional. This lifetime license for Windows is only $12.72 with code MARCH15 until March 29 (MSRP $249.99). Sometimes ideas ...

Know what message you’re trying to communicate before you get down in the weeds. by Scott Berinato Not long ago, the ability to create smart data visualizations, or dataviz, was a nice-to-have skill.

From market cap to ETF weightings, these visuals show how much the Magnificent 7 shape today’s market. Vikki Velasquez is a researcher and writer who has managed, coordinated, and directed various ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

U.S. News compares companies to their industry peers based on a variety of company fundamentals, performance metrics and investor preferences to help you find the right stocks for your investing style ...